Fortress Biotech, Inc.
USD2.95
+0.19 (+6.88%)
CEO
Lindsay Allan Rosenwald
IPO Date
2011-11-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.90
Prev. Close
$2.76
Day Low
$2.73
Day High
$2.95
52W Low
$1.75
52W High
$4.53
Market Cap
$0.10B
Volume
0.53M
| 2,967 |
| $2.18 |
| 20 Mar 2026 | ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: PRESIDENT, CEO & CHAIRMAN | A-Award | Acquired | 475,424 | $0.00 |
| 20 Mar 2026 | WEISS MICHAEL S | director, officer: Executive Vice Chairman | A-Award | Acquired | 475,424 | $0.00 |
| 5 Jan 2026 | Klein Dov | director | A-Award | Acquired | 27,322 | $0.00 |
| 5 Jan 2026 | Harvey Jimmie | director | A-Award | Acquired | 27,322 | $0.00 |
| 5 Jan 2026 | Lorenz Kevin | director | A-Award | Acquired | 27,322 | $0.00 |
| 5 Jan 2026 | Hoenlein Malcolm | director | A-Award | Acquired | 27,322 | $0.00 |
| 5 Jan 2026 | LOBELL J JAY | director | A-Award | Acquired | 27,322 | $0.00 |
| 2 Oct 2025 | Jin David | Chief Financial Officer | A-Award | Acquired | 2,711 | $1.31 |